高级搜索
经皮股动脉植入导管药盒系统治疗转移性肝癌[J]. 肿瘤防治研究, 2001, 28(03): 237-238. DOI: 10.3971/j.issn.1000-8578.2140
引用本文: 经皮股动脉植入导管药盒系统治疗转移性肝癌[J]. 肿瘤防治研究, 2001, 28(03): 237-238. DOI: 10.3971/j.issn.1000-8578.2140
Percutanesously Transfemoral Artery Implantation of PCS for Arterial Infusion Therapy of Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2001, 28(03): 237-238. DOI: 10.3971/j.issn.1000-8578.2140
Citation: Percutanesously Transfemoral Artery Implantation of PCS for Arterial Infusion Therapy of Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2001, 28(03): 237-238. DOI: 10.3971/j.issn.1000-8578.2140

经皮股动脉植入导管药盒系统治疗转移性肝癌

Percutanesously Transfemoral Artery Implantation of PCS for Arterial Infusion Therapy of Liver Metastases

  • 摘要: 目的 探讨经皮股动脉植入导管药盒系统的临床疗效。方法  30例转移性肝癌采用经皮股动脉植入导管药盒系统。依据肿瘤供血特点, 在透视监控下, 施行导管药盒系统植入式。结果 CR3例、PR1 4例、CR+PR5 6 .7%, 半年生存率 1 0 0 %, 1年生存率 5 3.3% (1 6 / 30 ), 2年生存率1 6 .7% (5 / 30 ), 无 1例严重并发症发生。结论 经皮股动脉植入导管药盒系统治疗转移性肝癌是安全可行, 有效的。

     

    Abstract: Objective To evaluate the Clinical effect of percutaneous transfemoral artery implantation of prot-catheter system(PCS) Methods 30 patients with liver metastases were treated by intra-arterial infusion therapy using PCS implanted by percutaneously transfemoral artey. We perfomed implantation of PCS under fluoroscopy according to blood supply artery of tumor. Results CR 3 cases,PR 14 cases, CR+PR 56.7%, The 1/2, 1-, and2-year overall survival rate was 100%, 53.3% and 16.7%, respectively. Serious complic...

     

/

返回文章
返回